Key result
Solid left atrial myxomas are linked to ~4x more CHF presentations than embolic-prone papillary types.
Why the study?
Most case series on atrial myxoma have focused on clinical presentation rather than correlating gross and microscopic tumor features with clinical manifestations.
Do different morphologic types of left atrial myxoma (papillary vs. solid) present with different clinical features?
Observational (n=68)
No
Do different morphologic types of left atrial myxoma (papillary vs. solid) present with different clinical features?
The gross morphologic type and location of left atrial myxomas (solid vs. papillary) predict their clinical presentation, with solid tumors more often causing fever, heart failure, and dyspnea.
Answers are grounded in this paper and cite their sources.
Morphologic classification of atrial myxoma may refine clinical correlation; leaves open confirmation in larger prospective cohorts.
Background: Atrial myxoma is the most common benign cardiac neoplasm. Most of the case series have focused on the variable clinical presentation of myxoma rather than its gross and microscopic features. The objective of our study was to evaluate prevalence of different morphologic types of myxoma and to correlate with their clinical presentations.Methods: 68 patients were included in the study. The study population was divided into two groups- Group-A (n-18) patients having soft (papillary) tumor in the left atrium, Group B (n=50) patients having solid tumor in the left atrium.Results: 88.3% patients suffered illness more than 12 months. 92% of the solid myxomas were located in the septal wall compared to 55.6% of the papillary myxomas (p = 0.031), while one-third (33.3%) the papillary tumors were found in the left atrial free wall compared to only 4% of the solid myxomas (p = 0.048). Fever, congestive heart failure and dyspnoea were significantly predominant in patients with solid myxomas (72% vs. 44.4%, p = 0.036; 92% vs. 22.2%, p < 0.001 and 88% vs. 55.6%, p = 0.010 respectively). Atrial fibrillation and neurologic manifestations were more frequently encountered in the papillary myxoma group. No statistically significant difference was found between the groups (p>0.05) by postoperative complication during in hospital follow up but one mortality in each group.Conclusion: Our findings lend support to the view that different gross left atrial Myxoma tumor types and tumor location predict presentation.Cardiovasc. j. 2015; 8(1): 19-22
No takes yet. Share an insight, caveat, or question.
Rahman et al. (2015) conducted an observational in Left atrial myxoma (n=68). Solid left atrial myxoma vs. Papillary left atrial myxoma was evaluated on Presentation with congestive heart failure (CHF) (p=< 0.001). Solid left atrial myxomas predominantly presented with congestive heart failure, while papillary myxomas were more likely to present with neurologic and embolic events.
Synapse has enriched 10 related papers. Consider them for comparative context: